Lavipharm S.A.
Lavipharm S.A. (Greece) is linked to 1 FDA-registered manufacturing site. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “Lavipharm S.A.: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/lavipharm-s-a
Overview
Lavipharm S.A. is a leading integrated pharmaceutical company in Greece, engaged in the research, development, production, and distribution of pharmaceuticals, cosmetics, and over-the-counter products. The company is known for its innovative transdermal therapeutic systems and collaborations with international partners.
Core services & business areas
Therapeutic areas
Registered manufacturing sites (1)
Physical sites registered with the US FDA and resolved to Lavipharm S.A., with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Lavipharm S.A. in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.
Is this Lavipharm S.A.?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.